Browsing by Author "Diklić, Aleksandar (6601959320)"
Now showing 1 - 8 of 8
- Results Per Page
- Sort Options
- Some of the metrics are blocked by yourconsent settings
Publication Biochemical and clinical characteristics of patients with primary aldosteronism-Single centre experience Biohemijske i kliničke karakteristike pacijenata sa primarnim aldosteronizmom-Iskustvo jednog centra(2020) ;Vujačić, Nataša (57211011760) ;Paunović, Ivan (55990696700) ;Diklić, Aleksandar (6601959320) ;Å Ivaljević, Vladan (57211012161) ;Slijepčević, Nikola (35811197900) ;Kalezić, Nevena (6602526969) ;Stojković, Mirjana (7006722691) ;Stojanović, Miloš (58202803500) ;Beleslin, Biljana (6701355427) ;Å Arković, Miloš (57211013098)Ć Irić, Jasmina (57211011691)Primary aldosteronism (PA) is associated with increased prevalence of metabolic disorders (impaired glucose and lipid metabolism and insulin resistance), but also with more frequent cardiovascular, renal and central nervous system complications. Biochemical and clinical parameters were retrospectively analysed for 40 patients with PA caused by aldosterone-producing adenoma (APA) and compared to the control groups of 40 patients with nonfunctioning adrenal adenoma (NFA) and essential hypertension (HT), and 20 patients with adrenal Cushing syndrome (CS) or subclinical CS (SCS). Systolic, diastolic and mean arterial blood pressures were significantly higher in the PA group (p=0.004; p=0.002; p=0.001, respectively) than in NFA+HT group. PA patients had longer hypertension history (p=0.001) than patients with hypercorticism and all had hypokalaemia. This group showed the smallest mean tumour diameter (p<0.001). The metabolic syndrome was significantly less common in the PA group (37.5% vs. 70% in CS+SCS and 65% in NFA+HT group; p=0.015), although there was no significant difference in any of the analysed metabolic parameters between groups. PA group was found to have the most patients with glucose intolerance (81.8%), although the difference was not significant. The mean BMI for all three groups was in the overweight range. Patients with PA had higher microalbuminuria and a higher tendency for cardiovascular, renal and cerebrovascular events, but the difference was not significant. Our results support the importance of the early recognition of primary aldosteronism on the bases of clinical presentation, as well as an increased screening intensity. © 2019 © 2019. - Some of the metrics are blocked by yourconsent settings
Publication Biochemical and clinical characteristics of patients with primary aldosteronism-Single centre experience Biohemijske i kliničke karakteristike pacijenata sa primarnim aldosteronizmom-Iskustvo jednog centra(2020) ;Vujačić, Nataša (57211011760) ;Paunović, Ivan (55990696700) ;Diklić, Aleksandar (6601959320) ;Å Ivaljević, Vladan (57211012161) ;Slijepčević, Nikola (35811197900) ;Kalezić, Nevena (6602526969) ;Stojković, Mirjana (7006722691) ;Stojanović, Miloš (58202803500) ;Beleslin, Biljana (6701355427) ;Å Arković, Miloš (57211013098)Ć Irić, Jasmina (57211011691)Primary aldosteronism (PA) is associated with increased prevalence of metabolic disorders (impaired glucose and lipid metabolism and insulin resistance), but also with more frequent cardiovascular, renal and central nervous system complications. Biochemical and clinical parameters were retrospectively analysed for 40 patients with PA caused by aldosterone-producing adenoma (APA) and compared to the control groups of 40 patients with nonfunctioning adrenal adenoma (NFA) and essential hypertension (HT), and 20 patients with adrenal Cushing syndrome (CS) or subclinical CS (SCS). Systolic, diastolic and mean arterial blood pressures were significantly higher in the PA group (p=0.004; p=0.002; p=0.001, respectively) than in NFA+HT group. PA patients had longer hypertension history (p=0.001) than patients with hypercorticism and all had hypokalaemia. This group showed the smallest mean tumour diameter (p<0.001). The metabolic syndrome was significantly less common in the PA group (37.5% vs. 70% in CS+SCS and 65% in NFA+HT group; p=0.015), although there was no significant difference in any of the analysed metabolic parameters between groups. PA group was found to have the most patients with glucose intolerance (81.8%), although the difference was not significant. The mean BMI for all three groups was in the overweight range. Patients with PA had higher microalbuminuria and a higher tendency for cardiovascular, renal and cerebrovascular events, but the difference was not significant. Our results support the importance of the early recognition of primary aldosteronism on the bases of clinical presentation, as well as an increased screening intensity. © 2019 © 2019. - Some of the metrics are blocked by yourconsent settings
Publication Contemporary approach to preoperative preparation of patients with adrenal cortex hormones dysfunction.(2011) ;Kalezić, Nevena (6602526969) ;Malenković, Vesna (57210140412) ;Zivaljević, Vladan (6701787012) ;Sabljak, Vera (51764228500) ;Diklić, Aleksandar (6601959320)Ivan, Paunović (25930881300)Preoperative preparation of the patients with adrenal cortex dysfunction is based on the careful preoperative evaluation of the type and the severity of the disturbance. The dysfunction involving adrenal glands may be: insufficiency (severe, mild, expressed) and hyperfunction (hypercorticism and/or hyperaldosteronism). If we speak about the patients with limited adrenal reserve (Addison's disease, therapeutic glucocorticoid application etc.) they need necessary corticosteroid supplementation, during preoperative preparation, as well as, during complete perioperative period. Doses needed for the substitution are adjusted according to the severity of adrenal insufficiency and according to the extent of the planned surgical procedure. Patients with Cushing's syndrome (or other form of hypercorticism), as well as, patients with Conn's syndrome (or other forms of hyperaldosteronism), do have numerous organ dysfunctions, that are significant in preoperative preparation, anesthesia and for the outcome of the surgical treatment. Common feature for both of the above syndromes is hydroelectrolyte disbalance, with hypokalemia, metabolic alkalosis and hypertension. Disturbances related to the adrenal cortex hyperfunction must be corrected preoperatively, in order to avoid complications. When we speak about hypokalemia it must be promptly corrected even before urgent/vital surgical procedure because it may cause severe intraoperative cardiac arrhythmia. - Some of the metrics are blocked by yourconsent settings
Publication Expression of VHL tumor suppressor mRNA and miR-92a in papillary thyroid carcinoma and their correlation with clinical and pathological parameters(2018) ;Todorović, Lidija (55243309900) ;Stanojević, Boban (56018770300) ;Mandušić, Vesna (16203425000) ;Petrović, Nina (7006674563) ;Živaljević, Vladan (6701787012) ;Paunović, Ivan (55990696700) ;Diklić, Aleksandar (6601959320) ;Saenko, Vladimir (35391278600)Yamashita, Shunichi (35392475600)A growing body of evidence suggests a role of the von Hippel–Lindau (VHL) tumor suppressor gene in the progression of papillary thyroid carcinoma (PTC). Our previous study of VHL in PTCs showed that lower VHL expression was associated with aggressive tumor features, but we found no evidence for VHL downregulation through common genetic or epigenetic modifications. Several studies pointed to a role of microRNA-92a (miR-92a) in the regulation of VHL expression in different cancers. In the present study, we examined the expression levels of VHL mRNA and miR-92a in 42 pairs of PTCs and matched non-tumor thyroid tissues by means of quantitative RT-PCR. We explored the correlation between them and their association with clinicopathological parameters. The results revealed that both VHL and miR-92a were either up- or downregulated in PTCs compared to corresponding non-tumor tissues. On univariate analysis, lower VHL levels were significantly associated with extrathyroid spread (P = 0.022) and capsular invasion (P = 0.032). Multivariate analysis confirmed the association of low VHL with extrathyroid spread (OR 0.246, 95% CI 0.069–0.872, P = 0.038). Higher miR-92a among PTC tissues associated with the presence of nodal metastases (univariate analysis: P = 0.012; multivariate: OR 4.703, 95% CI 1.109–19.938, P = 0.036). A negative correlation between VHL and miR-92a was observed in a subgroup of PTCs having vascular invasion (P = 0.033, r = − 0.673). The data here reported demonstrate that the expression of both VHL and miR-92a is deregulated in PTC tissues and that in some PTCs they may have opposite roles. These roles, as well as their diagnostic and/or prognostic utility, remain to be clarified. © 2017, Springer Science+Business Media, LLC, part of Springer Nature. - Some of the metrics are blocked by yourconsent settings
Publication Expression of VHL tumor suppressor mRNA and miR-92a in papillary thyroid carcinoma and their correlation with clinical and pathological parameters(2018) ;Todorović, Lidija (55243309900) ;Stanojević, Boban (56018770300) ;Mandušić, Vesna (16203425000) ;Petrović, Nina (7006674563) ;Živaljević, Vladan (6701787012) ;Paunović, Ivan (55990696700) ;Diklić, Aleksandar (6601959320) ;Saenko, Vladimir (35391278600)Yamashita, Shunichi (35392475600)A growing body of evidence suggests a role of the von Hippel–Lindau (VHL) tumor suppressor gene in the progression of papillary thyroid carcinoma (PTC). Our previous study of VHL in PTCs showed that lower VHL expression was associated with aggressive tumor features, but we found no evidence for VHL downregulation through common genetic or epigenetic modifications. Several studies pointed to a role of microRNA-92a (miR-92a) in the regulation of VHL expression in different cancers. In the present study, we examined the expression levels of VHL mRNA and miR-92a in 42 pairs of PTCs and matched non-tumor thyroid tissues by means of quantitative RT-PCR. We explored the correlation between them and their association with clinicopathological parameters. The results revealed that both VHL and miR-92a were either up- or downregulated in PTCs compared to corresponding non-tumor tissues. On univariate analysis, lower VHL levels were significantly associated with extrathyroid spread (P = 0.022) and capsular invasion (P = 0.032). Multivariate analysis confirmed the association of low VHL with extrathyroid spread (OR 0.246, 95% CI 0.069–0.872, P = 0.038). Higher miR-92a among PTC tissues associated with the presence of nodal metastases (univariate analysis: P = 0.012; multivariate: OR 4.703, 95% CI 1.109–19.938, P = 0.036). A negative correlation between VHL and miR-92a was observed in a subgroup of PTCs having vascular invasion (P = 0.033, r = − 0.673). The data here reported demonstrate that the expression of both VHL and miR-92a is deregulated in PTC tissues and that in some PTCs they may have opposite roles. These roles, as well as their diagnostic and/or prognostic utility, remain to be clarified. © 2017, Springer Science+Business Media, LLC, part of Springer Nature. - Some of the metrics are blocked by yourconsent settings
Publication Modified hemoglobin in hypoglycemia caused by hyperinsulinism(1991) ;Niketić, Vesna (6603686053) ;Marić, Sonja (36784637600) ;Diklić, Aleksandar (6601959320) ;Nešković, Smiljana (6505976435)Tomašević, Nenad (57188688201)Hemoglobin (Hb) was found to be modified in patients with prolonged hypoglycemia caused by hyperinsulinism. This modification was of a nonpolar nature, did not affect the overall charge of the Hb and caused its aggregation in aqueous solution. After normal concentrations of glucose and insulin were reestablished, this modification slowly disappeared. Hemoglobin from normal erythrocytes incubated in vitro with high concentrations of insulin showed similar behavior. © 1991. - Some of the metrics are blocked by yourconsent settings
Publication Modified hemoglobin in hypoglycemia caused by hyperinsulinism(1991) ;Niketić, Vesna (6603686053) ;Marić, Sonja (36784637600) ;Diklić, Aleksandar (6601959320) ;Nešković, Smiljana (6505976435)Tomašević, Nenad (57188688201)Hemoglobin (Hb) was found to be modified in patients with prolonged hypoglycemia caused by hyperinsulinism. This modification was of a nonpolar nature, did not affect the overall charge of the Hb and caused its aggregation in aqueous solution. After normal concentrations of glucose and insulin were reestablished, this modification slowly disappeared. Hemoglobin from normal erythrocytes incubated in vitro with high concentrations of insulin showed similar behavior. © 1991. - Some of the metrics are blocked by yourconsent settings
Publication Preoperative preparation of patients with hyperparathyroidism as comorbidity.(2011) ;Zivaljević, Vladan (6701787012) ;Kalezić, Nevena (6602526969) ;Jovanović, Dijana (7102247094) ;Sabljak, Vera (51764228500) ;Diklić, Aleksandar (6601959320)Paunovi, Ivan (51764410700)Preoperative preparation of patients with hyperarathyroidism planned to be operated and/or already operated because of some other disease have specific characteristics in function of the type of hyperparathyroidism, primary or secondary. In primary hyperparathyroidism, repercussions of pronounced hypercalcemia on organs and systems are of essential importance. The most important aspect of preoperative preparation of these patients is therefore the treatment of hypercalcemia. In patients with secondary hyperparathyroidism as comorbidity, calcium level is of lesser importance since it stays mostly within reference values. Essential for perioperative preparation of these patients is the fact that they have chronic renal insufficiency and usually are on extrarenal depuration, so that uremic toxic disorders important for the perioperative course should be taken into account. Disorders caused by primary or secondary hyperparathyroidism (and terminal chronic renal insufficiency) must be brough to so-called "stable state" in elective surgical interventions. Preoperative preparation in urgent surgical interventions is focused only on vitally endangering consequences of hyperparathyroidism such as hypercalcemic crisis or extreme hyperkalemia.